Concepedia

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana, Charles C. Wykoff, Taiji Sakamoto, Peter H. Win, Sunir Joshi, Hani Salehi-Had, András Seres, Alyson J. Berliner,

The Lancet · 2024 · 113 citations · 21 references

DOI

Concepts

References

21

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

N.H. Cho, Jonathan E. Shaw, Suvi Karuranga et al. · Diabetes Research and Clinical Practice · 2018 · 7.4K citations

, , +12

Ranibizumab for Diabetic Macular Edema

Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology · 2012 · 1.6K citations

, , +10

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Pravin U. Dugel, Adrian Koh, Yuichiro Ogura et al. · Ophthalmology · 2019 · 911 citations · Full text

, , +16

Intravitreal Aflibercept for Diabetic Macular Edema

Jean‐François Korobelnik, V. Diana, Ursula Schmidt‐Erfurth et al. · Ophthalmology · 2014 · 807 citations · Full text

, , +14

Diabetic Retinopathy Preferred Practice Pattern®

Christina J. Flaxel, Ron A. Adelman, Steven T. Bailey et al. · Ophthalmology · 2019 · 706 citations

, , +7